Gregory MSActivation of Kir4.1 Channels by 2‐D08 Promotes Myelin Repair in Multiple Sclerosis
A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Subjects Diagnosed With Epilepsy (X-TOLE4)
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-502282-24-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
An Exploratory, Multicenter, Randomized, double-blind, placebo-controlled study evaluating the effect and safety of pitolisant in children and adolescents with Autism Spectrum Disorders.
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-503678-18-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
A Phase 2 Safety, Tolerability, and Proof-of-Concept Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia (ALSP)
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-502505-15-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
A Randomized, Double-blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures (X-ACKT)
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-502286-16-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in Subjects With Parkinson’s Disease With a Pathogenic Variant in the Glucocerebrosidase (GBA1) Gene
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-501783-18-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-502000-73-00
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple Sclerosis
https://clinicaltrials.gov/study/NCT07008378?cond=Multiple+Sclerosis
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
Effect of Bobath Therapy on Balance Alterations in Patients With Multiple Sclerosis
https://clinicaltrials.gov/study/NCT07006259?cond=Multiple+Sclerosis
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis
https://clinicaltrials.gov/study/NCT07006805?cond=Multiple+Sclerosis
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS